KU-177 是 Hsp90 ATP 酶同系物 1 (Aha1) 的有效抑制剂,可消融 Aha1 驱动的 Hsp90 依赖性 tau 聚集增强,并干扰 Aha1/Hsp90 相互作用 (IC50=4.08 μM),但不影响 Hsp90 的再折叠荧光素酶的能力,同时可抑制癌细胞生长并诱导凋亡 (apoptosis),可用于 Tau 病的研究。
产品编号: MS-O12625 纯度: 98.54% CAS No.: 1160952-43-1 分子式: C27H23NO8 分子量: 489.47
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
50mg
询价
询价

产品描述

KU-177 是 Hsp90 ATP 酶同系物 1 (Aha1) 的有效抑制剂,可消融 Aha1 驱动的 Hsp90 依赖性 tau 聚集增强,并干扰 Aha1/Hsp90 相互作用 (IC50=4.08 μM),但不影响 Hsp90 的再折叠荧光素酶的能力,同时可抑制癌细胞生长并诱导凋亡 (apoptosis),可用于 Tau 病的研究。

生物实验数据

生物活性 KU-177 is a potent inhibitor of Hsp90 ATPase homolog 1 (Aha1) that abolishes Aha1-driven enhancement of Hsp90-dependent tau aggregation, interferes with the Aha1/Hsp90 interaction (IC50=4.08 μM) without affecting the ability of Hsp90 to refold luciferase, and inhibits cancer cell growth and induces apoptosis (apoptosis), making it useful for research on tauopathies.
IC50 & Target Aha1/HSP90:4.08 μM
体外研究
(In Vitro)

KU-177 (50 μM; 48 h) hampers the proliferation of flow MRD-positive cells in both primary multiple myeloma (MM) and recurrent MM patient samples.
KU-177 (30 μM; 48 h) inhibits proteasome activity in AHSA1 WT/OE cells, PSMD2 WT/OE cells and ANBL6 WT/DR cells.
KU-177 abrogates the cellular proliferation and PI resistance induced by elevated AHSA1, and decreases the expression of CDK6 and PSMD2.
KU-177 (25 μM; 30 min; 37 °C) inhibits recombinant P301L tau aggregation without inhibiting Hsp90 to refold luciferase.
KU-177 (10 μM; 24 h) exhibits the ability to disrupt interactions between Aha1 and Hsp90 in SH-SY5Y neuroblastoma cells and SK-BR-3 breast cancer cells, without significantly inhibition on Hsp90 client protein (Her2).

Cell Proliferation Assay

Cell Line: ARP1 and H929 WT and AHSA1-OE cells
Concentration: 1 nM-100 μM
Incubation Time: 24, 48, 72 hours
Result: Decreased multiple myeloma (MM) cell proliferation and PI resistance induced by AHSA1/HSP90 in vitro.

Cell Proliferation Assay

Cell Line: SH-SY5Y neuroblastoma cells and Her2 overexpressing SK-BR-3 breast cancer cells
Concentration: 10 μM
Incubation Time: 24 hours
Result: Didn’t induce the degradation of Hsp90 client proteins Her2 (in SK-BR-3 cells), Cdk6, or pAktS473 (in SHSY5Y cells), nor induced the expression of Hsp70, a marker of the heat shock response.
体内研究
(In Vivo)

KU-177 (1 mg/kg; i.p.; twice a week; 4 weeks), inhibits tumor growth and extends the survival of 5TMM3VT MM mice without significant toxicity. KU-177 shows stronger efficacy in vivo, combined with Bortezomib.html" class="link-product" target="_blank">Bortezomib (MS-D47138) (1 mg/kg; i.p.).

Animal Model: 5TMM3VT mouse model (6-8 weeks old, C57BL/KaLwrij mice)
Dosage: 1 mg/kg
Administration: Intraperitoneal injection; twice a week; sacrificed mice with hindlimb weakness immediately, about 4-5 weeks
Result: Inhibited the xenograft tumor growth of both ANBL6 WT/BTZ-DR cells.
Didn’t induce histopathological abnormities or lesions in main organs including heart, liver, spleen, lung and kidney.
性状 固体
颜色 White to off-white

化学信息

分子量 489.47
分子式 C27H23NO8
CAS No. 1160952-43-1

储存&溶解度

储存方式
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础